107 related articles for article (PubMed ID: 32223583)
1. The Humanistic and Economic Burden of Pediatric Focal Seizures in the United States.
Gibbs SN; Choi J; Khilfeh I; Ahmed KH; Yermilov I; Segal E
J Child Neurol; 2020 Jul; 35(8):543-555. PubMed ID: 32223583
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
3. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.
Gupta S; Kwan P; Faught E; Tsong W; Forsythe A; Ryvlin P
Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686
[TBL] [Abstract][Full Text] [Related]
4. Incremental burden of mental health conditions in adult patients with focal seizures.
Petrilla AA; Sutton BS; Leinwand BI; Parente A; Ferrari L; Wade CT
Epilepsy Behav; 2020 Nov; 112():107426. PubMed ID: 32961390
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
Chen SY; Wu N; Boulanger L; Sacco P
J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of focal onset seizures in children aged >1 month to 4 years in Europe, United States, and Canada: A literature review.
Schubert-Bast S; Kaur M; Joeres L; Foskett N; Roebling R; Strzelczyk A
Seizure; 2023 Nov; 112():88-97. PubMed ID: 37778299
[TBL] [Abstract][Full Text] [Related]
7. The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis.
Reaven NL; Funk SE; Lyons PD; Story TJ
Epilepsy Behav; 2019 Apr; 93():65-72. PubMed ID: 30831405
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
[TBL] [Abstract][Full Text] [Related]
9. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.
Väätäinen S; Soini E; Peltola J; Charokopou M; Taiha M; Kälviäinen R
Adv Ther; 2020 Jan; 37(1):477-500. PubMed ID: 31808053
[TBL] [Abstract][Full Text] [Related]
10. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis.
Covanis A
Pediatrics; 2006 Oct; 118(4):e1237-43. PubMed ID: 16950946
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
O'Brien TJ; Borghs S; He QJ; Schulz AL; Yates S; Biton V
Epilepsia; 2020 Apr; 61(4):636-646. PubMed ID: 32221987
[TBL] [Abstract][Full Text] [Related]
12. The burden of epilepsy and unmet need in people with focal seizures.
Ioannou P; Foster DL; Sander JW; Dupont S; Gil-Nagel A; Drogon O'Flaherty E; Alvarez-Baron E; Medjedovic J
Brain Behav; 2022 Sep; 12(9):e2589. PubMed ID: 36017757
[TBL] [Abstract][Full Text] [Related]
13. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
18. Impact of epilepsy and antiepileptic drugs on health and quality of life in Indian children.
Nagabushana D; S PK; Agadi JB
Epilepsy Behav; 2019 Apr; 93():43-48. PubMed ID: 30831401
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
Ettinger AB; Manjunath R; Candrilli SD; Davis KL
Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
